MFDS
- Marketing authorisation holder: EMERGENT BIODEFENSE
- Status: likely_approved
🇰🇷 Tembexa in South Korea
Tembexa (BRINCIDOFOVIR) regulatory status in South Korea.
Marketing authorisation
Tembexa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in South Korea
Frequently asked questions
Is Tembexa approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Tembexa in South Korea?
EMERGENT BIODEFENSE holds the South Korean marketing authorisation.